Therapeutic modulation of the intestinal creatine kinase system in inflammatory bowel disease (IBD)
Primary Objective
Specific Aim 1: Determine whether creatine supplementation induces improvement in the endoscopic assessment of mucosal inflammation in ulcerative colitis (UC). Specific Aim 2: Evaluate the feasibility of the current study protocol. Specific Aim 3: Assess the impact of creatine supplementation on intestinal epithelial barrier function and the intestinal microbiome.
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Scope
Local
Locations
Outpatient CTRC
University of Colorado Hospital
Study ID
Protocol Number: 13-3054
More information available at ClinicalTrials.gov: NCT02463305
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers